Who are Novo Nordisk's investors?

Novo Nordisk's investors include HM Venture Partners, Novo Holdings.

Where is Novo Nordisk headquartered?

Novo Nordisk is headquartered in Copenhagen, DK.

Novo Nordisk

Copenhagen, DK · Founded 1923 · 62,246 employees on LinkedIn · 2 known investors

Find your way into Novo Nordisk

378 people in our graph share verified history with the Novo Nordisk team — schools, employers, funds. One of them is your warm intro.

Michael Lintsunlockedknows Maziar Mike Doustdar · together at Harvard Business School (overlapped)

×10knows the team · via Harvard Business School

knows the team · via Novo Nordisk

Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies. It serves patients and healthcare markets globally.

Biotech Healthtech

Founders & leadership

Maziar Mike Doustdar inPresident and CEOMaziar Mike Doustdar is CEO of Novo Nordisk, a pharmaceutical company developing treatments for diabetes, obesity, and other chronic diseases.

Investors · 2

HM Venture PartnersSan Francisco

Novo HoldingsCopenhagen · $1.1M – $54M

Founder mafia

The Novo Nordisk mafia →

14 people who came through Novo Nordisk went on to found or lead other companies.

Kunal SardaManagerFounded Arya For Work +1 Jan Møller MikkelsenVice President, Protein DiscoveryFounded Ascendis Pharma Quin WillsHead of Cellular and Systems Genomics, Novo Nordisk Research Centre OxfordFounded Ochre Bio Sebastian BitschEngineer in Advanced Robotics @ Aseptic ManufacturingFounded Rencom Mads BondeCommunication ConsultantFounded Labster Alexander JungeSenior Data ScientistFounded Amass Jan JensenPhD studentFounded Trailhead Biosystems Julia ReganAssociate Manager ePrescribing & Digital StrategyFounded RxLightning Brit BerrySenior Manager Device Partnerships and ScoutingFounded Avenda Health Jørgen DamSenior Project ManagerFounded Cbio Anders OdumPh.D. StudentFounded Chromologics Daniel Gewecke DaugaardBusiness ConsultantFounded Dawnhealth

+ 2 more

Competitors · 3

by search overlap

Eli Lilly1028 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.

Ro938 shared keywordsRo is an online healthcare platform that connects patients with licensed providers and delivers prescription treatments, including GLP-1 medications for weight loss, ED treatments, and other health goals. The direct-to-consumer telehealth service is fully online and serves individual patients in the United States.

Medscape867 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies competing with Novo Nordisk for the same Google search keywords, organic and paid, via search-intersection analysis.

Acquisitions · 5

Early investors' stakes continue via these deals

Calibrium

Calibrium was an Indiana-based biopharmaceutical startup founded in 2013 that developed novel peptide and insulin-based drug candidates for diabetes and obesity.

Dicerna

Dicerna Pharmaceuticals was a biotechnology company developing RNA interference (RNAi) therapeutics for rare and genetic diseases and oncology using its GalXC platform.

Forma Therapeutics

Clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare hematologic diseases and cancers, acquired by Novo Nordisk in 2022.

Inversago

Portfolio company acquired by Novo Nordisk for $1.1B USD.

KBP

Hypertension company acquired by Novo Nordisk.

Frequently asked questions

What does Novo Nordisk do?: Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies. It serves patients and healthcare markets globally.
Who are Novo Nordisk's investors?: Novo Nordisk's investors include HM Venture Partners, Novo Holdings.
Where is Novo Nordisk headquartered?: Novo Nordisk is headquartered in Copenhagen, DK.